HealthEquity (HQY) Stock Forecast, Price Target & Predictions
HQY Stock Forecast
HealthEquity stock forecast is as follows: an average price target of $97.00 (represents a 11.56% upside from HQY’s last price of $86.95) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
HQY Price Target
The average price target for HealthEquity (HQY) is $97.00 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $110.00 to $85.00. This represents a potential 11.56% upside from HQY's last price of $86.95.
HQY Analyst Ratings
According to 11 Wall Street analysts, HealthEquity's rating consensus is 'Buy'. The analyst rating breakdown for HQY stock is 0 'Strong Buy' (0.00%), 10 'Buy' (90.91%), 1 'Hold' (9.09%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
HealthEquity Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 04, 2024 | George Hill | Deutsche Bank | $103.00 | $82.66 | 24.61% | 18.46% |
| Jun 20, 2024 | Stan Berenshteyn | Wells Fargo | $110.00 | $84.74 | 29.81% | 26.51% |
| Jun 04, 2024 | Scott Schoenhaus | KeyBanc | $100.00 | $83.40 | 19.90% | 15.01% |
| Jun 04, 2024 | Mark Marcon | Robert W. Baird | $104.00 | $81.22 | 28.05% | 19.61% |
| Jun 03, 2024 | Alexander Paris | Barrington | $100.00 | $81.03 | 23.41% | 15.01% |
| May 07, 2024 | Stan Berenshteyn | Wells Fargo | $105.00 | $79.27 | 32.46% | 20.76% |
| Apr 04, 2024 | Constantine Davides | JMP Securities | $101.00 | $79.90 | 26.41% | 16.16% |
| Mar 28, 2024 | Glen Santangelo | Jefferies | $95.00 | $79.72 | 19.17% | 9.26% |
| Mar 20, 2024 | Stephanie Davis | Barclays | $104.00 | $81.36 | 27.83% | 19.61% |
| Mar 20, 2024 | Sean Dodge | RBC Capital | $92.00 | $81.36 | 13.08% | 5.81% |
The latest HealthEquity stock forecast, released on Sep 04, 2024 by George Hill from Deutsche Bank, set a price target of $103.00, which represents a 24.61% increase from the stock price at the time of the forecast ($82.66), and a 18.46% increase from HQY last price ($86.95).
HealthEquity Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 10 |
| Avg Price Target | - | $103.00 | $101.40 |
| Last Closing Price | $86.95 | $86.95 | $86.95 |
| Upside/Downside | -100.00% | 18.46% | 16.62% |
In the current month, the average price target of HealthEquity stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to HealthEquity's last price of $86.95. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 20, 2024 | RBC Capital | Buy | Buy | Hold |
| Sep 19, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Sep 04, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Sep 04, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Jun 04, 2024 | Wells Fargo | Buy | Buy | Hold |
| Jun 04, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Jun 04, 2024 | Bank of America Securities | Buy | Buy | Hold |
| Jun 04, 2024 | JMP Securities | Outperform | Outperform | Hold |
| Jun 04, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Jun 03, 2024 | Jefferies | Buy | Buy | Hold |
HealthEquity's last stock rating was published by RBC Capital on Sep 20, 2024. The company gave HQY a "Buy" rating, the same as its previous rate.
HealthEquity Financial Forecast
HealthEquity Revenue Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $262.39M | $249.22M | $243.55M | - | $233.84M | $216.09M | $206.14M | - | $203.30M | $179.95M | $189.10M | - | $188.17M | $179.35M | $176.04M | - | $201.20M | $157.12M |
| Avg Forecast | $396.74M | $376.94M | $375.00M | $376.81M | $344.43M | $324.59M | $328.28M | $326.63M | $304.23M | $289.92M | $285.13M | $277.91M | $258.69M | $243.61M | $239.96M | $239.39M | $230.73M | $206.79M | $203.88M | $203.98M | $199.88M | $183.97M | $185.09M | $181.20M | $185.78M | $176.82M | $171.28M | $193.72M | $199.31M | $152.09M |
| High Forecast | $403.10M | $382.98M | $381.01M | $382.85M | $349.95M | $329.79M | $333.54M | $331.87M | $309.36M | $293.32M | $285.13M | $277.91M | $258.84M | $252.26M | $243.81M | $243.23M | $234.43M | $209.95M | $207.00M | $207.11M | $202.94M | $186.79M | $187.93M | $183.98M | $188.63M | $179.53M | $173.91M | $196.69M | $202.37M | $154.42M |
| Low Forecast | $392.80M | $373.19M | $371.27M | $373.06M | $341.00M | $321.36M | $325.01M | $323.38M | $301.44M | $287.21M | $285.13M | $277.91M | $258.55M | $239.68M | $237.58M | $237.01M | $228.43M | $203.87M | $201.01M | $201.11M | $197.07M | $181.39M | $182.49M | $178.65M | $183.17M | $174.33M | $168.88M | $191.00M | $196.51M | $149.95M |
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.02% | 1.01% | - | 1.01% | 1.04% | 1.01% | - | 1.02% | 0.98% | 1.02% | - | 1.01% | 1.01% | 1.03% | - | 1.01% | 1.03% |
HealthEquity's average Quarter revenue forecast for May 24 based on 6 analysts is $277.91M, with a low forecast of $277.91M, and a high forecast of $277.91M. HQY's average Quarter revenue forecast represents a 5.92% increase compared to the company's last Quarter revenue of $262.39M (Jan 24).
HealthEquity EBITDA Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $79.08M | $30.89M | $24.74M | - | $59.90M | $52.99M | $46.04M | - | $5.81M | $36.30M | $32.52M | - | $35.85M | $40.46M | $36.80M | - | $40.37M | $-1.96M |
| Avg Forecast | $103.49M | $98.33M | $97.82M | $98.29M | $89.85M | $84.67M | $85.63M | $85.21M | $79.36M | $75.63M | $74.38M | $7.67M | $67.48M | $63.55M | $62.60M | $6.97M | $39.93M | $53.94M | $53.18M | $6.33M | $52.14M | $47.99M | $48.28M | $34.06M | $48.46M | $46.12M | $44.68M | $35.76M | $51.99M | $39.67M |
| High Forecast | $105.15M | $99.90M | $99.39M | $99.87M | $91.29M | $86.03M | $87.01M | $86.57M | $80.70M | $76.51M | $74.38M | $9.20M | $67.52M | $65.80M | $63.60M | $8.36M | $47.92M | $54.77M | $54.00M | $7.60M | $52.94M | $48.73M | $49.02M | $40.87M | $49.21M | $46.83M | $45.37M | $42.91M | $52.79M | $40.28M |
| Low Forecast | $102.46M | $97.35M | $96.85M | $97.32M | $88.95M | $83.83M | $84.78M | $84.36M | $78.63M | $74.92M | $74.38M | $6.13M | $67.44M | $62.52M | $61.97M | $5.57M | $31.94M | $53.18M | $52.44M | $5.07M | $51.41M | $47.32M | $47.60M | $27.24M | $47.78M | $45.48M | $44.05M | $28.61M | $51.26M | $39.12M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.17% | 0.49% | 0.40% | - | 1.50% | 0.98% | 0.87% | - | 0.11% | 0.76% | 0.67% | - | 0.74% | 0.88% | 0.82% | - | 0.78% | -0.05% |
6 analysts predict HQY's average Quarter EBITDA for May 24 to be $7.67M, with a high of $9.20M and a low of $6.13M. This is -90.31% lower than HealthEquity's previous annual EBITDA (Jan 24) of $79.08M.
HealthEquity Net Income Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $26.36M | $14.67M | $10.58M | - | $-209.00K | $-1.64M | $-10.65M | - | $-32.82M | $-5.04M | $-3.82M | - | $5.37M | $1.79M | $-148.00K | - | $-190.00K | $-21.33M |
| Avg Forecast | - | - | - | - | $85.16M | $80.53M | $82.39M | $79.08M | $64.56M | $63.49M | $61.97M | $-43.32M | $50.34M | $44.32M | $42.28M | $-39.38M | $-5.54M | $30.72M | $29.27M | $-35.80M | $19.02M | $30.74M | $32.16M | $5.10M | $35.88M | $31.77M | $24.30M | $-168.28K | $31.13M | $19.26M |
| High Forecast | - | - | - | - | $86.93M | $82.21M | $84.11M | $80.73M | $68.92M | $67.06M | $61.97M | $-34.66M | $51.06M | $48.84M | $43.16M | $-31.51M | $-4.43M | $31.33M | $29.85M | $-28.64M | $19.40M | $31.35M | $32.80M | $6.12M | $36.59M | $32.40M | $24.78M | $-134.63K | $31.75M | $19.64M |
| Low Forecast | - | - | - | - | $84.05M | $79.49M | $81.32M | $78.05M | $61.07M | $61.70M | $61.97M | $-51.98M | $49.63M | $42.51M | $41.74M | $-47.26M | $-6.65M | $30.16M | $28.73M | $-42.96M | $18.67M | $30.18M | $31.57M | $4.08M | $35.22M | $31.19M | $23.85M | $-201.94K | $30.56M | $18.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.52% | 0.33% | 0.25% | - | 0.04% | -0.05% | -0.36% | - | -1.73% | -0.16% | -0.12% | - | 0.15% | 0.06% | -0.01% | - | -0.01% | -1.11% |
HealthEquity's average Quarter net income forecast for May 24 is $-43.32M, with a range of $-51.98M to $-34.66M. HQY's average Quarter net income forecast represents a -264.31% decrease compared to the company's last Quarter net income of $26.36M (Jan 24).
HealthEquity SG&A Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $43.70M | $46.03M | $46.21M | - | $40.03M | $42.38M | $41.78M | - | $37.19M | $32.73M | $38.29M | - | $36.37M | $34.98M | $32.66M | - | $37.30M | $31.88M |
| Avg Forecast | $74.79M | $71.06M | $70.70M | $71.04M | $64.93M | $61.19M | $61.89M | $61.58M | $57.35M | $54.66M | $53.75M | $49.09M | $48.77M | $45.92M | $45.24M | $44.63M | $36.00M | $38.98M | $38.43M | $40.57M | $37.68M | $34.68M | $34.89M | $34.55M | $35.02M | $33.33M | $32.29M | $33.04M | $37.57M | $28.67M |
| High Forecast | $75.99M | $72.20M | $71.83M | $72.18M | $65.97M | $62.17M | $62.88M | $62.57M | $58.32M | $55.30M | $53.75M | $58.91M | $48.80M | $47.56M | $45.96M | $53.56M | $43.20M | $39.58M | $39.02M | $48.69M | $38.26M | $35.21M | $35.43M | $41.46M | $35.56M | $33.84M | $32.79M | $39.65M | $38.15M | $29.11M |
| Low Forecast | $74.05M | $70.35M | $69.99M | $70.33M | $64.29M | $60.58M | $61.27M | $60.96M | $56.83M | $54.14M | $53.75M | $39.28M | $48.74M | $45.18M | $44.79M | $35.71M | $28.80M | $38.43M | $37.89M | $32.46M | $37.15M | $34.20M | $34.40M | $27.64M | $34.53M | $32.87M | $31.84M | $26.43M | $37.05M | $28.27M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 1.00% | 1.02% | - | 1.11% | 1.09% | 1.09% | - | 0.99% | 0.94% | 1.10% | - | 1.04% | 1.05% | 1.01% | - | 0.99% | 1.11% |
HealthEquity's average Quarter SG&A projection for May 24 is $49.09M, based on 6 Wall Street analysts, with a range of $39.28M to $58.91M. The forecast indicates a 12.35% rise compared to HQY last annual SG&A of $43.70M (Jan 24).
HealthEquity EPS Forecast
| Jan 27 | Oct 26 | Jul 26 | May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 24 | Oct 23 | Jul 23 | May 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | May 20 | Jan 20 | Oct 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 5 | 4 | 8 | 5 | 3 | 3 | 6 | 9 | 9 | 4 | 6 | 4 | 8 | 4 | 6 | 4 | 5 | 3 | 5 | 3 | 6 | 4 | 6 | 4 | 6 | 6 | 6 | 6 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.31 | $0.17 | $0.12 | - | $-0.00 | $-0.02 | $-0.13 | - | $-0.39 | $-0.06 | $-0.05 | - | $0.07 | $0.02 | $-0.00 | - | $-0.00 | $-0.30 |
| Avg Forecast | - | - | - | - | $0.96 | $0.91 | $0.93 | $0.89 | $0.73 | $0.72 | $0.70 | $0.66 | $0.57 | $0.50 | $0.48 | $0.41 | $0.35 | $0.35 | $0.33 | $0.26 | $0.21 | $0.35 | $0.36 | $0.32 | $0.40 | $0.36 | $0.27 | $0.44 | $0.35 | $0.22 |
| High Forecast | - | - | - | - | $0.98 | $0.93 | $0.95 | $0.91 | $0.78 | $0.76 | $0.70 | $0.66 | $0.58 | $0.55 | $0.49 | $0.41 | $0.36 | $0.35 | $0.34 | $0.27 | $0.22 | $0.35 | $0.37 | $0.33 | $0.41 | $0.37 | $0.28 | $0.44 | $0.36 | $0.22 |
| Low Forecast | - | - | - | - | $0.95 | $0.90 | $0.92 | $0.88 | $0.69 | $0.70 | $0.70 | $0.66 | $0.56 | $0.48 | $0.47 | $0.40 | $0.34 | $0.34 | $0.32 | $0.26 | $0.21 | $0.34 | $0.36 | $0.32 | $0.40 | $0.35 | $0.27 | $0.43 | $0.34 | $0.21 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.55% | 0.34% | 0.25% | - | -0.01% | -0.06% | -0.39% | - | -1.82% | -0.17% | -0.14% | - | 0.17% | 0.06% | -0.01% | - | -0.01% | -1.38% |
According to 6 Wall Street analysts, HealthEquity's projected average Quarter EPS for May 24 is $0.66, with a low estimate of $0.66 and a high estimate of $0.66. This represents a 111.73% increase compared to HQY previous annual EPS of $0.31 (Jan 24).
HealthEquity Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| APPF | AppFolio | $212.00 | $278.00 | 31.13% | Buy |
| LOPE | Grand Canyon Education | $137.33 | $166.00 | 20.88% | Buy |
| HQY | HealthEquity | $86.95 | $97.00 | 11.56% | Buy |
| GMED | Globus Medical | $74.72 | $79.54 | 6.45% | Buy |
| NEWR | New Relic | $86.99 | $86.38 | -0.70% | Buy |
| OLLI | Ollie's Bargain Outlet | $95.50 | $80.57 | -15.63% | Buy |
HQY Forecast FAQ
Is HealthEquity a good buy?
Yes, according to 11 Wall Street analysts, HealthEquity (HQY) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 10 'Buy' recommendations, accounting for 90.91% of HQY's total ratings.
What is HQY's price target?
HealthEquity (HQY) average price target is $97 with a range of $85 to $110, implying a 11.56% from its last price of $86.95. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will HealthEquity stock go up soon?
According to Wall Street analysts' prediction for HQY stock, the company can go up by 11.56% (from the last price of $86.95 to the average price target of $97), up by 26.51% based on the highest stock price target, and down by -2.24% based on the lowest stock price target.
Can HealthEquity stock reach $130?
HQY's average twelve months analyst stock price target of $97 does not support the claim that HealthEquity can reach $130 in the near future.
What are HealthEquity's analysts' financial forecasts?
HealthEquity's analysts financial forecasts for the fiscal year (Jan 2026) are as follows: average revenue is $1.32B (high $1.35B, low $1.31B), average EBITDA is $345.36M (high $350.89M, low $341.92M), average net income is $327.15M (high $333.97M, low $322.92M), average SG&A $249.59M (high $253.59M, low $247.1M), and average EPS is $3.69 (high $3.77, low $3.64). HQY's analysts financial forecasts for the fiscal year (Jan 2027) are as follows: average revenue is $1.53B (high $1.55B, low $1.51B), average EBITDA is $397.94M (high $404.32M, low $393.98M), average net income is $0 (high $0, low $0), average SG&A $287.59M (high $292.2M, low $284.73M), and average EPS is $0 (high $0, low $0).
Did the HQY's actual financial results beat the analysts' financial forecasts?
Based on HealthEquity's last annual report (Jan 2024), the company's revenue was $999.59M, beating the average analysts forecast of $981.65M by 1.83%. Apple's EBITDA was $281.21M, beating the average prediction of $200.59M by 40.19%. The company's net income was $55.71M, missing the average estimation of $97.56M by -42.89%. Apple's SG&A was $182.93M, missing the average forecast of $184.56M by -0.89%. Lastly, the company's EPS was $0.65, missing the average prediction of $1.95 by -66.67%. In terms of the last quarterly report (Jan 2024), HealthEquity's revenue was $262.39M, beating the average analysts' forecast of $258.69M by 1.43%. The company's EBITDA was $79.08M, beating the average prediction of $67.48M by 17.18%. HealthEquity's net income was $26.36M, missing the average estimation of $50.34M by -47.63%. The company's SG&A was $43.7M, missing the average forecast of $48.77M by -10.40%. Lastly, the company's EPS was $0.31, missing the average prediction of $0.568 by -45.41%